79
32
Growth Score
-6 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3804503
GNI is to pursue strategic synergies and maximize investment effects
- Ying Luo: President and CEO
About the Company
GNI is a Japanese subsidiary of the US corporation Gene Networks, Inc.(2008 liquidation) and started with basic research on gene analysis by a small team of young scientists. Later, it was listed on the Tokyo Stock Exchange Mothers in 2007 and launched in 2014 as a full-fledged pharmaceutical company by launching a new drug. The Group has business
bases in China and Japan, two of the world's largest economies, and has its own pharmaceutical factory in China, thereby conducting integrated business activities from new drug discovery and clinical development to manufacturing and sales. This is extremely rare in the biotech industry.
